ETACRYNIC ACID
Pediatric ALL
Duke UniversitySmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
26 Active assets in the Pediatric ALL cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Beclomethasone New York City Health and Hospitals Corporation | Phase 4 | BB |
ROPIVACAINE Yilin Zhao | Phase 4 | BB |
NALBUPHINE Ain Shams University | Phase 4 | BB |
BIVALIRUDIN University of Texas Southwestern Medical Center | Phase 4 | BB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Ain Shams University | Phase 4 | BB |
View all 40 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →